H. McFarland

发表

Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history

N. Patronas, Jonathan O. Harris, Joseph Frank, 1991, Annals of neurology.

A. Compston, S. Reingold, A. Thompson, 2001, Annals of neurology.

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

S. Reingold, A. Thompson, M. Filippi, 2005, Annals of neurology.

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

L. Staudt, A. Rosenwald, J. Frank, 2003, Brain : a journal of neurology.

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

J. Taubenberger, D. McFarlin, H. McFarland, 1993, Annals of neurology.

Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.

V. Ikonomidou, I. Evangelou, H. McFarland, 2010, Archives of neurology.

The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.

D. Reich, N. Shiee, H. McFarland, 2013, Multiple sclerosis and related disorders.

Examination of the role of MRI in multiple sclerosis: a problem orientated approach.

H. McFarland, 2010, Results and problems in cell differentiation.

Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach

Henry F. McFarland, H. McFarland, 2009, Annals of Indian Academy of Neurology.

The role of MRI as a surrogate outcome measure in multiple sclerosis

F Barkhof, F. Barkhof, D. Miller, 2002, Multiple sclerosis.

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis

J L Ostuni, H. McFarland, H. McFarland, 2001, Multiple sclerosis.

Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.

H. McFarland, S. Jacobson, M. Brennan, 2000, The Journal of infectious diseases.

Multiple sclerosis: a complicated picture of autoimmunity

Roland Martin, Roland Martin, H. McFarland, 2007, Nature Immunology.

In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

M Riva, L. Pezawas, L. Pezawas, 2006, AJNR. American journal of neuroradiology.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

Roland G. Henry, Robert Zivadinov, Daniel S. Reich, 2016, Nature Reviews Neurology.

Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.

Nancy Richert, Joseph A Frank, Joan Ohayon, 2009, Archives of neurology.

HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells

Eric O Long, H. McFarland, R. Sékaly, 1989, Journal of virology.

Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones

Roland Martin, B. Hemmer, H. McFarland, 1998, Journal of Neuroimmunology.

Measles virus-specific cellular immunity in patients with vaccine failure

McFarland, H. McFarland, D. Griffin, 1993, Journal of clinical microbiology.

Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging

S. Pillemer, H. McFarland, K. Morgen, 2004 .

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

P. Calabresi, H. McFarland, M. Levin, 1998, Neurology.

The Immune Response to Viruses

H. McFarland, S. Jacobson, 1989 .

Proton MR spectroscopic imaging in multiple sclerosis

S. Bonavita, J. Frank, G. Tedeschi, 2002, Neuroradiology.

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

Eric O Long, D. McFarlin, H. McFarland, 1991, The Journal of experimental medicine.

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation

Roland Martin, H. McFarland, M. Racke, 1992, Journal of Neuroimmunology.

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7

Roland Martin, H. McFarland, B. Bielekova, 1999, Journal of Neuroimmunology.

Impaired renal function in progressive multiple sclerosis

P. Choyke, P. Calabresi, H. McFarland, 2002, Neurology.

Manganese-Enhanced MRI in Patients with Multiple Sclerosis

D. Reich, A. Koretsky, H. McFarland, 2020, American Journal of Neuroradiology.

Megadose corticosteroids in multiple sclerosis

S. Reingold, D. Paty, D. Kaufman, 1994, Neurology.

Computed tomography and magnetic resonance imaging in adult-onset leukodystrophy.

N. Patronas, H. McFarland, R. Eldridge, 1988, Archives of neurology.

Linkage analysis in spinopontine atrophy: correlation of HLA linkage with phenotypic findings in hereditary ataxia.

S. Bale, H. McFarland, A. Bale, 1987, American journal of medical genetics.

Multiple Sclerosis Support the Etiologic Role of DRB5*01:01 in TCR/HLA-DRB5*01:01 Transgenic Mice Myelin Basic Protein-Specific

C. Pinilla, Roland Martin, H. McFarland, 2012 .

Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

E. Jaffe, J. Heiss, N. Patronas, 1997, The New England journal of medicine.

In vitro studies of cell-mediated immunity in an acute viral infection.

H. McFarland, 1974, Journal of immunology.

Measles virus persistence in human lymphocytes: a role for virus-induced interferon.

H. McFarland, S. Jacobson, 1982, The Journal of general virology.

Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis

U. Utz, Roland Martin, D. McFarlin, 1993, Nature.

T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors

L. Amaducci, Roland Martin, H. McFarland, 1998, Journal of Neuroimmunology.

Immunology of Multiple Sclerosis

H. McFarland, 1988, Annals of the New York Academy of Sciences.

Induction of experimental allergic encephalomyelitis in the NIH minipig

J. Frank, H. McFarland, W. Biddison, 2000, Journal of Neuroimmunology.

Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure

P. Calabresi, P. Albert, J. Frank, 1997, Neurology.

Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis

T. R. Peters, D. McFarlin, H. McFarland, 2000, Journal of Neuroimmunology.

Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.

B. Hemmer, H. McFarland, R. Martin, 1997, Journal of immunology.

Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99)

U. Utz, L. Steinman, Roland Martin, 1996, European journal of immunology.

Identification of a second T cell epitore of human proteolipid protein (residues 89–106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

H. McFarland, J. Trotter, C. Pelfrey, 1994, Journal of Neuroimmunology.

Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

H. McFarland, J. Trotter, C. Pelfrey, 1993, Journal of Neuroimmunology.

Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

Eric O Long, D. McFarlin, H. McFarland, 1990, Journal of immunology.

T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells

Eric O Long, B. Hemmer, H. McFarland, 1997, Journal of Neuroimmunology.

From specificity to degeneracy to molecular mimicry: Antigen recognition of human autoreactive and pathogen-specific CD4+ T cells

C. Pinilla, B. Hemmer, H. McFarland, 1998, Journal of Neuroimmunology.

Multiple sclerosis: Are HLA class I molecules involved in disease pathogenesis?

H. McFarland, R. Martin, 1995, Annals of neurology.

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides

R. Karr, A. Cross, H. McFarland, 1997, Journal of Neuroimmunology.

Adrenergic dysfunction in hereditary adult‐onset leukodystrophy

H. McFarland, R. Polinsky, R. Eldridge, 1987, Neurology.

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

H. McFarland, R. Martin, D. Scott, 1997, Journal of Neuroimmunology.

The path to damage in multiple sclerosis

H. McFarland, 1999, Annals of neurology.

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays.

J. Trent, P. Munson, K. Becker, 1999, Annals of neurology.

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

Frauke Zipp, Arno Villringer, Peter Brunecker, 2004, Brain : a journal of neurology.

Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.

U. Utz, H. McFarland, R. Martin, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The multiple sclerosis lesion

H. McFarland, 1995, Annals of neurology.

Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model.

H. McFarland, 1994, The Journal of clinical investigation.

Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis

H. McFarland, L. Massacesi, S. Jacobson, 2001, Annals of neurology.

Intravenous antigen adrmnistration as a therapy for autoimmune demyelinating disease

H. McFarland, M. Lenardo, C. Raine, 1996, Annals of neurology.

Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens.

H. McFarland, R. Hartzman, S. Jacobson, 1984, Journal of immunology.

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

H. McFarland, C. Raine, M. Racke, 1999, The American journal of pathology.

HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.

Eric O Long, H. McFarland, R. Martin, 1990, Journal of immunology.

Chronic Relapsing Experimental Autoimmune Encephalomyelitis: Effects of Insulin‐like Growth Factor‐I Treatment on Clinical Deficits, Lesion Severity, Glial Responses, and Blood Brain Barrier Defects

H. Webster, H. McFarland, L. Hudson, 1998, Journal of neuropathology and experimental neurology.

Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype

B. Hemmer, H. McFarland, R. Martin, 1997, Neurology.

Multiple sclerosis in twins

D. McFarlin, H. McFarland, R. Eldridge, 1980, Neurology.

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.

J. Trent, B. Freidlin, K. Becker, 1998, Proceedings of the National Academy of Sciences of the United States of America.

T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects

H. McFarland, J. Trotter, C. Pelfrey, 1998, Journal of Neuroimmunology.

Gene-Marked Autologous Hematopoietic Stem Cell Transplantation of Autoimmune Disease

H. McFarland, H. Heslop, G. Firestein, 2004, Journal of Clinical Immunology.

CNS vasculitis in a patient with MS on daclizumab monotherapy

A. Vortmeyer, H. McFarland, N. Richert, 2013, Neurology.

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells

C. Kufta, H. McFarland, S. Dhib-jalbut, 1990, Journal of Neuroimmunology.

Measles virus-specific human T cell clones: Studies of alloreactivity and antigenic cross-reactivity

E. D. Robinson, D. McFarlin, H. McFarland, 1988, Journal of Neuroimmunology.

Studies of multiple sclerosis in twins

D. McFarlin, H. McFarland, R. Eldridge, 1983, Trends in Neurosciences.

Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain.

Eric O Long, H. McFarland, R. Sékaly, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Twin studies and multiple sclerosis

H. McFarland, 1992, Annals of neurology.

Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus.

W. Bellini, D. McFarlin, H. McFarland, 1983, The Journal of infectious diseases.

Chronic measles encephalitis in mice.

D. McFarlin, H. McFarland, K. Rammohan, 1980, The Journal of infectious diseases.

DR2/DQwl Inheritance and haplotype sharing in affected siblings from multiple sclergis families

A. Goldstein, H. McFarland, R. Voskuhl, 1996 .

A functional basis for the association of HLA class II genes adn susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family

Roland Martin, H. McFarland, R. Voskuhl, 1993, Journal of Neuroimmunology.

T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination

D. McFarlin, H. McFarland, R. Voskuhl, 1993, Journal of Neuroimmunology.

Characterization of Cerebrospinal Fluid Lymphocytes in Multiple Sclerosis a

Xian-hua Xu, D. McFarlin, H. McFarland, 1984, Annals of the New York Academy of Sciences.

Expansion of antigen-specific T cells from cerebrospinal fluid of patients with multiple sclerosis

D. McFarlin, H. McFarland, J. Richert, 1983, Journal of Neuroimmunology.

Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis

D. McFarlin, H. McFarland, J. Sever, 1988, Journal of virology.

Book Review Multiple Sclerosis as a Neuronal Disease Edited by Stephen G. Waxman. 484 pp., illustrated. San Diego, Calif., Elsevier Academic Press, 2005. $170. 0-12-738761-7

H. McFarland, 2005 .

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

J. Frank, Roland Martin, H. McFarland, 2000, Nature Medicine.

The importance of clinical trials in unraveling the mysteries of multiple sclerosis

H. McFarland, 2011, Journal of Neuroimmunology.

New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab

H. McFarland, 2009 .

MEASLES VIRUS INFECTION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: IMPORTANCE OF THE OKT4+ T-CELL SUBSET1

H. McFarland, S. Jacobson, 1984 .

Interferon-β interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes

H. McFarland, R. Martin, P. Muraro, 1997, Neurology.

T‐cell Receptor Use in Multiple Sclerosis

U. Utz, H. McFarland, R. Martin, 1995, Annals of the New York Academy of Sciences.

Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis

Roland Martin, D. McFarlin, H. McFarland, 1993, Annals of neurology.

Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones

Roland Martin, H. McFarland, P. Muraro, 1999, Journal of Neuroimmunology.

Multiple sclerosis patients have reduced HLA class II-restricted cytotoxic responses specific for both measles and herpes virus

H. McFarland, S. D. de Silva, 1991, Journal of Neuroimmunology.

Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.

C. Bever, N. Patronas, H. McFarland, 1984, The New England journal of medicine.

Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays

J. Trent, P. Munson, K. Becker, 1999 .

Deficient expression in multiple sclerosis of the inhibitory transcription factor SP3 in mononuclear blood cells

E. D. Robinson, H. McFarland, P. Katz, 1996, Annals of neurology.

Diversity of T-cell receptor Valpha, Vbeta, and CDR3 expression by myelin basic protein-specific human T-cell clones

E. D. Robinson, K. Camphausen, H. McFarland, 1995, Neurology.

Virus‐Specific Cytotoxic T Cells in Multiple Sclerosis

H. McFarland, A. Goodman, S. Jacobson, 1988, Annals of the New York Academy of Sciences.

Lack of over-expression of T cell receptor Vβ5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls

Roland Martin, H. McFarland, P. Muraro, 1998, Journal of Neuroimmunology.

Natalizumab and immune cells.

H. McFarland, S. Jacobson, 2006, Archives of neurology.

Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

H. McFarland, S. Jacobson, S. Soldan, 2000, Annals of neurology.

Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination

D. McFarlin, H. McFarland, R. Voskuhl, 1994, Journal of Neuroimmunology.

In vitro modulation of human, autoreactive MBP-specific CD4+ T-cell clones by cyclosporin A

Roland Martin, H. McFarland, P. Muraro, 1997, Journal of Neuroimmunology.

to TCR Ligand Potency Within MHC Molecule or Antigenic Peptide Contribution of Individual Amino Acids

R. Houghten, C. Pinilla, B. Hemmer, 1999 .

Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset.

J. Frank, H. McFarland, B. Lewis, 1999, AJNR. American journal of neuroradiology.

Brief Definitive Report Identification of a Specific Hla Dr2 Ia Molecule as a Restriction Element for Measles Virus- Specific Hla Class Ii-restricted Cytotoxic T Cell Clones

H. McFarland, G. Nepom, S. Jacobson, 2003 .

Brief Definitive Report Identification of a Specific Hla Dr2 Ia Molecule as a Restriction Element for Measles Virus- Specific Hla Class Ii-restricted Cytotoxic T Cell Clones

H. McFarland, G. Nepom, S. Jacobson, 2022 .

Virus-specific cytotoxic T lymphocytes in multiple sclerosis: a normal mumps virus response adds support for a distinct impairment in the measles virus response

H. McFarland, A. Goodman, S. Jacobson, 1989, Journal of Neuroimmunology.

2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases

Roland Martin, H. McFarland, R. Lichtenfels, 1997, Journal of Neuroimmunology.

Familial multiple sclerosis: Clinical, histocompatibility, and viral serological studies

H. McFarland, J. Sever, D. Sadowsky, 1978, Annals of neurology.

Human T lymphocytes specific for the immunodominant 83–99 epitope of myelin basic protein: Recognition of golli MBP HOG 7

C. Campagnoni, A. Campagnoni, B. Hemmer, 1996, Journal of neuroscience research.

Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83–99)

P. Calabresi, B. Hemmer, H. McFarland, 1996, Journal of neuroscience research.

A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.

H. McFarland, R. Martin, M. Vergelli, 1996, Journal of immunology.

Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac

J. D. White, T. Waldmann, H. McFarland, 1998, Annals of neurology.

Human T‐cell lymphotropic virus type II–associated myelopathy: Clinical and immunologic profiles

H. McFarland, T. Lehky, S. Jacobson, 1996, Annals of neurology.

The Role of T Cells in Multiple Sclerosis: Implications for Therapies Targeting the T Cell Receptor

U. Utz, H. McFarland, 1994, Journal of neuropathology and experimental neurology.

Corrections: Autoreactive CD8^+ T-Cell Responses to Human Myelin Protein- Derived Peptides

K. Parker, J. Coligan, H. McFarland, 1995 .

Acute encephalopathy caused by defective virus infection

H. McFarland, O. Narayan, R. Johnson, 1976, Neurology.

Training-dependent plasticity in patients with multiple sclerosis.

Alessandro Tessitore, Katrin Morgen, Lumy Sawaki, 2004, Brain : a journal of neurology.

Alemtuzumab versus interferon beta-1a: implications for pathology and trial design

H. McFarland, 2009, The Lancet Neurology.

Immunofluorescent Study of Circulating Antibody in Experimental Allergic Encephalomyelitis 1

H. McFarland, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Recognition of Intracellular Measles Virus Antigens by HLA Class II Restricted Measles Virus‐Specific Cytotoxic T Lymphocytes

W. Bellini, H. McFarland, R. Sékaly, 1988 .

MRI as a marker for disease heterogeneity in multiple sclerosis

G. Cutter, E. Fisher, Joseph Frank, 2005, Neurology.

Extended observations on the association of HHV-6 and multiple sclerosis.

H. McFarland, S. Jacobson, S. Soldan, 2000, Journal of neurovirology.

Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

T. Waldmann, J. Frank, Roland Martin, 2004 .

SPECIFICITY OF THE INFLAMMATORY RESPONSE IN VIRAL ENCEPHALITIS

H. McFarland, D. Griffin, Richard T. Johnson, 1972, The Journal of experimental medicine.

Comment on “Interleukin‐2/Interleukin‐2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation”

H. McFarland, B. Bielekova, 2012, Annals of neurology.

Kinematic specificity of cortical reorganization associated with motor training

Leonardo G. Cohen, Alessandro Tessitore, Katrin Morgen, 2004, NeuroImage.

Chapter 53 – Multiple Sclerosis

Roland Martin, R. Hohlfeld, H. McFarland, 2003 .

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.

H. McFarland, R. Martin, Roland Martin, 1995, Critical reviews in clinical laboratory sciences.

Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice.

H. McFarland, R. Johnson, S. E. Levy, 1972, The Journal of infectious diseases.

The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens.

D. McFarlin, H. McFarland, E. Mingioli, 1980, Journal of immunology.

Response of human lymphocytes to measles virus after natural infection

H. McFarland, J. Greenstein, Neuroimmunology, 1983, Infection and immunity.

Impaired human leukocyte antigen–restricted measles virus–specific cytotoxic T‐cell response in subacute sclerosing panencephalitis

D. McFarlin, H. McFarland, S. Jacobson, 1989, Annals of neurology.

Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis

D. McFarlin, H. McFarland, S. Dhib-jalbut, 1989, Journal of Neuroimmunology.

Immunological Responses to Viruses in Multiple Sclerosis: Cell-mediated Immunity

H. McFarland, J. Greenstein, 1982, Clinics in Immunology and Allergy.

Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin

D. McFarlin, H. McFarland, K. Rammohan, 1981, Nature.

Subacute sclerosing panencephalitis after passive immunization and natural measles infection

D. McFarlin, H. McFarland, K. Rammohan, 1982, Neurology.

SPECIFICITY OF THE INFLAMMATORY RESPONSE IN VIRAL ENCEPHALITIS

H. McFarland, D. Griffin, Richard T. Johnson, 1972, The Journal of experimental medicine.

Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR Vβ chain locus and HLA class II genes

L. Hood, D. McFarlin, H. McFarland, 1993, Journal of Neuroimmunology.

T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

H. McFarland, R. Martin, P. Muraro, 2002, Journal of Neuroimmunology.

Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.

Chao Zhao, R. Franklin, H. McFarland, 2013, Brain : a journal of neurology.

Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival.

R. Houghten, C. Pinilla, B. Hemmer, 2000, International immunology.

Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone

Bernhard Hemmer, Günther Jung, Karl-Heinz Wiesmüller, 1997, The Journal of experimental medicine.

Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis

C. Pinilla, Roland Martin, H. McFarland, 2012, The Journal of Immunology.

Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.

R. Simon, C. Pinilla, B. Hemmer, 2001, Journal of autoimmunity.

Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis.

H. McFarland, R. Martin, B. Bielekova, 2000, Journal of neural transmission. Supplementum.

Molecular mimicry and multiple sclerosis: Degenerate T‐cell recognition and the induction of autoimmunity

Roland Martin, B. Hemmer, H. McFarland, 1999, Annals of neurology.

The germline repertoire of T cell receptor β-chain genes in patients with chronic progressive multiple sclerosis

L. Hood, D. McFarlin, H. McFarland, 1989, Journal of Neuroimmunology.

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic eraa

S. Reingold, H. McFarland, 2005, Multiple sclerosis.

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

D. Douek, J. Nagle, Roland Martin, 2005, The Journal of experimental medicine.

Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.

Javed Khan, Markus Ringnér, Michael L Bittner, 2003, Human molecular genetics.

Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis.

L. Steinman, H. McFarland, L. Smith, 1994, The Journal of clinical investigation.

A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination

D. McFarlin, H. McFarland, R. Voskuhl, 1993, Journal of Neuroimmunology.

Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis

H. McFarland, S. Jacobson, M. Flerlage, 1985, The Journal of experimental medicine.

Family and Twin Studies in Multiple Sclerosis

Xian-hua Xu, D. McFarlin, H. McFarland, 1984, Annals of the New York Academy of Sciences.

T cell receptor usage in neurological disease: the case in multiple sclerosis

Roland Martin, H. McFarland, 1992 .

Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice

S. Ludwin, Roland Martin, H. McFarland, 2004, The Journal of experimental medicine.

Multiple sclerosis: Possible immunological mechanisms☆

H. McFarland, S. Dhib-jalbut, 1989, Clinical Immunology and Immunopathology.

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease

Yingdong Zhao, Clemencia Pinilla, Bernhard Hemmer, 1999, Nature Medicine.

CD4+CD28- costimulation-independent T cells in multiple sclerosis.

H. McFarland, R. Martin, I. Cortese, 2001, The Journal of clinical investigation.

Lymphocytapheresis in chronic progressive multiple sclerosis: Results of a preliminary trial

D. McFarlin, H. McFarland, J. Rose, 1983, Annals of neurology.

Monitoring relapsing remitting MS patients

E. Montgomery, D. Bourdette, H. McFarland, 1999, Journal of Neuroimmunology.

Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis

T. Su, D. Rubinow, H. McFarland, 1999, Biological Psychiatry.

Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis

H. McFarland, J. Butman, F. Bagnato, 2005, Journal of NeuroVirology.

Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

U. Utz, Roland Martin, H. McFarland, 2003, Brain : a journal of neurology.

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

D E Banks, J. Nagle, H. McFarland, 1997, The Journal of clinical investigation.

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing–remitting multiple sclerosis

M. Gobbini, J. Frank, H. McFarland, 1999, Journal of Neuroimmunology.

THE ROLE OF THE INFLAMMATORY RESPONSE IN VIRAL INFECTIONS

H. McFarland, Richard T. Johnson, 1975 .

Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.

H. McFarland, R. Eldridge, J. Schwankhaus, 1994, Archives of neurology.

Induction of measles virus-specific human cytotoxic T cells by purified measles virus nucleocapsid and hemagglutinin polypeptides.

D. McFarlin, H. McFarland, S. Jacobson, 1987, Viral immunology.

The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity.

H. McFarland, 1974, Journal of immunology.

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

T. Waldmann, M. Cerná, Roland Martin, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Selective neuronal, dendritic, and postsynaptic localization of viral antigen in measles-infected mice.

H. McFarland, K. Rammohan, M. Dubois‐Dalcq, 1979, Laboratory investigation; a journal of technical methods and pathology.

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Bernhard Hemmer, Gavin Giovannoni, Huub Schellekens, 2010, The Lancet Neurology.

FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome

J. Grafman, H. McFarland, K. Morgen, 2001, Neurology.

Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis

H. McFarland, N. Richert, F. Bagnato, 2005, Multiple sclerosis.

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.

E. D. Robinson, J. Coligan, U. Utz, 1992, Journal of immunology.

Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.

R. Houghten, C. Pinilla, B. Hemmer, 1998, Journal of immunology.

Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism

K. Becker, K. Parker, J. Coligan, 1997, Journal of Neuroimmunology.

ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions

P. Calabresi, J. Frank, H. McFarland, 1998, Journal of Neuroimmunology.

Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis

R. Simon, Roland Martin, H. McFarland, 2004, The Journal of Immunology.

T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes.

H. McFarland, R. Martin, R. Voskuhl, 1993, Autoimmunity.

Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes

L. Staudt, A. Rosenwald, Roland Martin, 2001, Annals of neurology.

The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis

J. Frank, H. McFarland, L. Stone, 1995, Annals of neurology.

Magnetic resonance imaging of labeled T‐cells in a mouse model of multiple sclerosis

Roland Martin, Joseph Frank, H. McFarland, 2004, Annals of neurology.

Intrathecal effects of daclizumab treatment of multiple sclerosis

T. Waldmann, Roland Martin, H. McFarland, 2011, Neurology.

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

S. Ludwin, H. McFarland, W. Biddison, 2001, Journal of Neuroimmunology.

CD 4 + CD 28 – costimulation-independent T cells in multiple sclerosis

Roland Martin, H. McFarland, I. Cortese, 2001 .

Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging.

S. Pillemer, H. McFarland, K. Morgen, 2004, Seminars in arthritis and rheumatism.

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

U. Utz, Roland Martin, H. McFarland, 1997, Journal of Neuroimmunology.

The germline repertoire of T-cell receptor beta-chain genes in patients with multiple sclerosis.

L. Hood, D. McFarlin, H. McFarland, 1989, Research in immunology.

Experimental immunotherapies for multiple sclerosis

Roland Martin, H. McFarland, 2004, Springer Seminars in Immunopathology.

Epitope spreading occurs in active but not passive EAE induced by myelin basic protein

H. McFarland, R. Voskuhl, K. Nagasato, 1996, Journal of Neuroimmunology.

Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

H. McFarland, N. Richert, S. Jacobson, 2009, Archives of neurology.

Regulatory T Cells Are Reduced During Anti-CD 25 Antibody Treatment of Multiple Sclerosis

H. McFarland, N. Richert, S. Jacobson, 2009 .

Preliminary trial of poly ICLC in chronic progressive multiple sclerosis

C. Bever, D. McFarlin, H. McFarland, 1986, Neurology.

Different Development of Myelin Basic Protein Agonist- and Antagonist-Specific Human TCR Transgenic T Cells in the Thymus and Periphery1

Roland Martin, H. McFarland, A. Necker, 2008, The Journal of Immunology.

Contribution of Individual Amino Acids Within MHC Molecule or Antigenic Peptide to TCR Ligand Potency1

Clemencia Pinilla, Bernhard Hemmer, Henry F. McFarland, 2000, The Journal of Immunology.

Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis

P. Albert, J. Frank, H. McFarland, 1995, Neurology.

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.

T. Waldmann, J. Frank, Roland Martin, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Multiple sclerosis : clinical and pathogenetic basis

Henry F. McFarland, Wallace W. Tourtellotte, H. McFarland, 1997 .

Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b

J. Dambrosia, P. Calabresi, Joseph Frank, 1997, Annals of neurology.

MRI and clinical activity in MS patients after terminating treatment with interferon beta-l b

B. Lewis, Joseph Frank, H. McFarland, 2000, Multiple sclerosis.

Introduction to the Special Issue

D. Reich, H. McFarland, S. Jacobson, 2017, Journal of Neuroimmunology.

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

S. Reingold, F. Lublin, J. Wolinsky, 1999, Annals of neurology.

Interferon‐β1a therapy in human T‐lymphotropic virus type I–associated neurologic disease

H. McFarland, J. Butman, F. Bagnato, 2005, Annals of neurology.

Multiple Sclerosis T Cells + High-Avidity Myelin-Specific CD 4 Expansion and Functional Relevance of

R. Simon, Roland Martin, H. McFarland, 2004 .

Multiple sclerosis: Re‐expression of a developmental gene in chronic lesions correlates with remyelination

H. McFarland, R. Voskuhl, C. Raine, 1997, Annals of neurology.

Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis

Roland Martin, H. McFarland, N. Richert, 2009, Multiple sclerosis.

Alternative designs for multiple sclerosis clinical trials

S. Reingold, H. McFarland, 2007 .

Title: Oral Administration of the Nitroxide Radical Tempol Exhibits Immunomodulatory and Therapeutic Properties in Multiple Sclerosis Models Running Title: Oral Tempol Limits Disease in Models of Ms

James B. Mitchell, H. McFarland, M. Cherukuri, 2022 .

Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis

H. McFarland, N. Richert, J. Ostuni, 2006, Neurology.

Contrast-enhanced MRI lesions during treatment with interferonβ-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis

H. McFarland, N. Richert, K. Morgen, 2005, Multiple sclerosis.

Expression pro ® ling identi ® es responder and non-responder phenotypes to interferon-b in multiple sclerosis

M. Sathyamoorthy, L. Staudt, A. Rosenwald, 2003 .

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFN&bgr;-1b

B. Lewis, H. McFarland, N. Richert, 2002, Neurology.

The Clinical and Social Impact of Interferon-β: The First Approved Therapy in Multiple Sclerosis

H. McFarland, 1999 .

The Application of Magnetic Resonance Imaging to Phase II Trials in Multiple Sclerosis

J. Frank, H. McFarland, 1999 .

Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.

J. Duyn, H. McFarland, N. Richert, 1998, AJNR. American journal of neuroradiology.

Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI

P. Calabresi, J. Frank, Joseph Frank, 1997, Neurology.

Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis

E. Fisher, H. McFarland, N. Richert, 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study

C. Pozzilli, H. McFarland, N. Richert, 2000, Multiple sclerosis.

Time series for modelling counts from a relapsing-remitting disease: application to modelling disease activity in multiple sclerosis.

J A Frank, P S Albert, P. Albert, 1994, Statistics in medicine.

Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences

A. Goldszal, D. Pham, B. Lewis, 2002, Multiple sclerosis.

In vivo three-dimensional MR microscopy of mice with chronic relapsing experimental autoimmune encephalomyelitis after treatment with insulin-like growth factor-I.

J A Frank, Y Yang, J. Frank, 1998, AJNR. American journal of neuroradiology.

The B cell--old player, new position on the team.

H. McFarland, 2008, The New England journal of medicine.

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

P. Calabresi, H. McFarland, P. Secchiero, 1997, Nature Medicine.

Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis

A. MacKenzie-Graham, H. McFarland, R. Voskuhl, 1996, Annals of neurology.

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

P. Calabresi, H. McFarland, E. Cowan, 1998, Journal of Neuroimmunology.

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

T. Waldmann, Roland Martin, H. McFarland, 2009, Archives of neurology.

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression

H. McFarland, S. Jacobson, M. Brennan, 2002, Journal of NeuroVirology.

T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis

R. Kane, V. Ikonomidou, H. McFarland, 2010, Multiple sclerosis.

Human antiidiotypic antibody against opiate receptors

W. Bowen, D. Murphy, D. McFarlin, 1988, Annals of neurology.

Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosis

J. Dichgans, P. Calabresi, F. Zipp, 1998, Annals of neurology.

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-β therapy in multiple sclerosis

H. McFarland, B. Bielekova, P. Muraro, 2000, Journal of Neuroimmunology.

65 – Multiple sclerosis

H. McFarland, I. Cortese, 2008 .

Citrulline‐containing myelin basic protein is recognized by T‐cell lines derived from multiple sclerosis patients and healthy individuals

H. McFarland, R. Martin, J. Whitaker, 1994, Neurology.

DR2/DQw1 inheritance and haplotype sharing in affected siblings from multiple sclerosis families.

A. Goldstein, H. McFarland, R. Voskuhl, 1996, Annals of Neurology.

Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

Roland Martin, J. Frank, Roland Martin, 1992, Annals of neurology.

Cortisol induction by poly ICLC: Implications for clinical trials of interferon

C. Bever, D. McFarlin, H. McFarland, 1988, Annals of neurology.

Polypeptide specificities of measles virus-reactive T cell lines and clones derived from a patient with multiple sclerosis.

D. McFarlin, H. McFarland, R. Hartzman, 1986, Journal of immunology.

Immunopathogenesis of the multiple sclerosis lesion

H. McFarland, S. Markovic‐Plese, S. Markovic-Plese, 2001, Current neurology and neuroscience reports.

Semi-automatic segmentation and modeling of the cervical spinal cord for volume quantification in multiple sclerosis patients from magnetic resonance images

Francesca Bagnato, Iordanis E. Evangelou, Pavlina Sonkova, 2008, SPIE Medical Imaging.

Correlation between MR and clinical findings of disease activity in multiple sclerosis.

H. McFarland, 1999, AJNR. American journal of neuroradiology.

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

Neal Jeffries, Joseph A Frank, J. Frank, 2003, Brain : a journal of neurology.

Ring and nodular multiple sclerosis lesions

H. McFarland, N. Richert, M. Riva, 2010, Neurology.

Immunotherapy of multiple sclerosis: Where are we? Where should we go?

Roland Martin, H. McFarland, C. Stürzebecher, 2001, Nature Immunology.

Diseases Involving Myelin

H. McFarland, P. Morell, R. Quarles, 1999 .

Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals.

H. McFarland, M. Lenardo, S. Boehme, 1995, Journal of immunology.

Use of magnetic resonance imaging in the diagnosis of multiple sclerosis

R. Herndon, D. Paty, W. Mcdonald, 1986, Neurology.

Pathologic Findings in a Newly Described, Adult‐Onset Leukodystrophy

H. McFarland, R. Eldridge, D. Katz, 1990 .

Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.

J. Coligan, B. Hemmer, H. McFarland, 1997, Journal of immunology.

Defective interfering particles modulate VSV infection of dissociated neuron cultures

H. McFarland, G. Faulkner, E. Hooghe-Peters, 1979, Cell.

Infection of the central nervous system produced by R1 vesicular stomatitis virus.

H. McFarland, R. Lazzarini, A. Baron-Van Evercooren, 1979, Laboratory investigation; a journal of technical methods and pathology.

Multiple Sclerosis: A Comprehensive Text

Reinhard Hohlfeld, R. Hohlfeld, H. McFarland, 2008 .

Clinical neuroimmunology: Multiple sclerosis

H. McFarland, 1987, Journal of Neuroimmunology.

Limited repertoire of HLA-DRB1*0401-restricted MBP111–129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential

S. Ludwin, Roland Martin, H. McFarland, 2004, Journal of Neuroimmunology.

Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: Observations from a post-mortem 3 Tesla imaging study

H. Merkle, B. Yao, H. McFarland, 2009, Journal of the Neurological Sciences.

The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis

J. Frank, H. McFarland, N. Richert, 2008, Expert opinion on biological therapy.

Serial contrast‐enhanced magnetic resonance imaging in patients with early relapsing–remitting multiple sclerosis: Implications for treatment trials

J A Frank, P S Albert, H. McFarland, 1994, Annals of neurology.

DIFFERENTIAL EXPRESSION OF A NOVEL CANDIDATE AUTOANTIGEN, X2 MBP, IN MULTIPLE SCLEROSIS (MS) LESIONS

H. McFarland, R. Voskuhl, C. Raine, 1996 .

A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients

B. Lewis, H. McFarland, N. Richert, 2002, Multiple sclerosis.

Ring-enhancement in multiple sclerosis: marker of disease severity

H. McFarland, N. Richert, K. Morgen, 2001, Multiple sclerosis.

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

P. Calabresi, H. McFarland, H. Maloni, 1997, Neurology.

How to participate in a multiple sclerosis clinical trial.

H. McFarland, J. Frank, 2000, Neuroimaging clinics of North America.

Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity

Roland Martin, H. McFarland, B. Bielekova, 2000, The Journal of Immunology.

Specificity and Functional Antigen Avidity Subsets Differ with Respect to Epitope + and Memory CD 45 RO + Naive CD 45 RA T Cells from + Human Autoreactive CD 4

Roland Martin, H. McFarland, B. Bielekova, 2000 .

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial

F. Lublin, J. Wolinsky, R. Rudick, 2023, Multiple sclerosis journal - experimental, translational and clinical.

Multiple Sclerosis Therapeutics: The growing need for alternative clinical trial designs for multiple sclerosis

S. Reingold, H. McFarland, A. Petkau, 2011 .

National Multiple Sclerosis Society Working Group on Neuroimaging for the Medical Advisory Board

R. Herndon, W. Mcdonald, J. Wolinsky, 1987, Neuroradiology.

Effect of Anti-CD 25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis

T. Waldmann, Roland Martin, H. McFarland, 2009 .

Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations.

J. Frank, H. McFarland, N. Richert, 2005, Archives of neurology.

Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis

I. Evangelou, H. McFarland, A. Gallo, 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein‐like material in patients with multiple sclerosis

D. Paty, H. McFarland, L. Stone, 1994, Annals of neurology.

Complexities in the Treatment of Autoimmune Disease

H. McFarland, H. Mcfarland, 1996, Science.

Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials.

D. Paty, H. McFarland, D W Paty, 1998, Journal of neurology, neurosurgery, and psychiatry.

Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis

H. McFarland, R. Martin, L. Stone, 1996, Journal of Neuroimmunology.

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.

M. Gobbini, J. Frank, H. McFarland, 2001, Archives of neurology.

Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation

J. Bulte, J. Frank, H. McFarland, 1998, Journal of Neuroscience Research.

Cerebrospinal Fluid Immunoglobulin Abnormalities in Multiple Sclerosis

D. McFarlin, H. McFarland, A. Goodman, 1987 .

Antiserums to neurons and to oligodendroglia from mammalian brain.

G. McKhann, H. McFarland, S. Poduslo, 1977, Science.

Multiple sclerosis (first of two parts).

D. McFarlin, H. McFarland, H. Mcfarland, 1982, The New England journal of medicine.

Thalamic Involvement and Its Impact on Clinical Disability in Patients with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3T

I. Evangelou, H. McFarland, F. Tovar-Moll, 2009, American Journal of Neuroradiology.

The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

S. Reingold, D. Miller, R. Grossman, 1998, Brain : a journal of neurology.

Immunological aspects of demyelinating diseases.

D. McFarlin, H. McFarland, R. Martin, 1992, Annual review of immunology.

Interferon beta-1b in secondary progressive MS

C. Pozzilli, L. Kappos, C. Polman, 2004, Neurology.

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Jeffrey A. Cohen, S. Reingold, M. Filippi, 2008, Multiple sclerosis.

H. McFarland, J. Sever, R. Eldridge, 1978 .

Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83–99)

P. Calabresi, B. Hemmer, H. McFarland, 1996, Journal of neuroscience research.

Interferon-&bgr;-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb− and NAb+ patients

P. Calabresi, P. Calabresi, H. McFarland, 2004, Neurology.

Human cellular immune response to measles virus polypeptides

W. Bellini, D. McFarlin, H. McFarland, 1984, Journal of virology.

Immune reactivity of the purified hemagglutinin of measles virus

W. Bellini, D. McFarlin, H. McFarland, 1981, Infection and immunity.

Viral antibodies in twins with multiple sclerosis

D. McFarlin, H. McFarland, P. Leinikki, 1985, Neurology.

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

S. Reingold, M. Filippi, L. Kappos, 2005, Annals of neurology.

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

Eric O Long, D. McFarlin, H. McFarland, 1991, The Journal of experimental medicine.

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides

R. Karr, A. Cross, H. McFarland, 1997, Journal of Neuroimmunology.

2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases

Roland Martin, H. McFarland, R. Lichtenfels, 1997, Journal of Neuroimmunology.

The B cell--old player, new position on the team.

H. McFarland, 2008, The New England journal of medicine.

Use of magnetic resonance imaging in the diagnosis of multiple sclerosis. Policy statement of the National Multiple Sclerosis Society, New York

R. Herndon, D. Paty, W. Mcdonald, 1986 .

Immunological Aspects of Multiple Sclerosis with Emphasis on the Potential Use of Autologous Hemopoietic Stem Cell Transplantation

Roland Martin, H. McFarland, P. Muraro, 2019, Stem Cell Therapy for Autoimmune Disease.

Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models

James B. Mitchell, H. McFarland, M. Cherukuri, 2017, Brain, Behavior, and Immunity.

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

J A Frank, J S Wolinsky, P S Tofts, 1998, Annals of neurology.

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

F. Barkhof, M. Filippi, F. Fazekas, 1999, Neurology.